Your account is not claimed yet. You can sign up with ORCID to claim your account.

Dimitrios T Trafalis (Dimitrios Trafalis)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 34

Top Venues

International journal of molecular sciences

Plants (Basel, Switzerland)

Molecules (Basel, Switzerland)

Pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Maria V Deligiorgi, Dimitrios T Trafalis
A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors. International journal of molecular sciences 24 (8) (2023)
Maria V Deligiorgi, Dimitrios T Trafalis
A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors. International journal of molecular sciences 24 (8) (2023)
Despoina Varna, Elena G Geromichalou, Georgia Karlioti, Rigini Papi, Panayiotis Dalezis, Antonios G Hatzidimitriou, George Psomas, Theodora Choli-Papadopoulou, Dimitrios T Trafalis, Panagiotis A Angaridis
Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH 3 -Substituted Thiadiazole-Based Thioamide. Molecules (Basel, Switzerland) 28 (1) (2023)
Maria V Deligiorgi, Dimitrios T Trafalis
A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors. International journal of molecular sciences 24 (8) (2023)
Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Despoina Varna, Elena G Geromichalou, Georgia Karlioti, Rigini Papi, Panayiotis Dalezis, Antonios G Hatzidimitriou, George Psomas, Theodora Choli-Papadopoulou, Dimitrios T Trafalis, Panagiotis A Angaridis
Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH 3 -Substituted Thiadiazole-Based Thioamide. Molecules (Basel, Switzerland) 28 (1) (2023)
Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Despoina Varna, Elena G Geromichalou, Georgia Karlioti, Rigini Papi, Panayiotis Dalezis, Antonios G Hatzidimitriou, George Psomas, Theodora Choli-Papadopoulou, Dimitrios T Trafalis, Panagiotis A Angaridis
Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH 3 -Substituted Thiadiazole-Based Thioamide. Molecules (Basel, Switzerland) 28 (1) (2023)
Maria V Deligiorgi, Dimitrios T Trafalis
A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors. International journal of molecular sciences 24 (8) (2023)
Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Despoina Varna, Elena G Geromichalou, Georgia Karlioti, Rigini Papi, Panayiotis Dalezis, Antonios G Hatzidimitriou, George Psomas, Theodora Choli-Papadopoulou, Dimitrios T Trafalis, Panagiotis A Angaridis
Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH 3 -Substituted Thiadiazole-Based Thioamide. Molecules (Basel, Switzerland) 28 (1) (2023)
Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Sotiris Kyriakou, Dimitrios T Trafalis, Maria V Deligiorgi, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Assessment of Methodological Pipelines for the Determination of Isothiocyanates Derived from Natural Sources. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Maria V Deligiorgi, Dimitrios T Trafalis
The continuum of care of anticancer treatment-induced hypothyroidism in patients with solid non-thyroid tumors: time for an intimate collaboration between oncologists and endocrinologists. Expert review of clinical pharmacology 15 (5) (2022)
Maria V Deligiorgi, Dimitrios T Trafalis
The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum. Journal of clinical medicine 11 (12) (2022)
Sotiris Kyriakou, Venetia Tragkola, Heba Alghol, Ioannis Anestopoulos, Tom Amery, Kyle Stewart, Paul G Winyard, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Evaluation of Bioactive Properties of Lipophilic Fractions of Edible and Non-Edible Parts of Nasturtium officinale (Watercress) in a Model of Human Malignant Melanoma Cells. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Despoina Varna, Elena Geromichalou, Antonios G Hatzidimitriou, Rigini Papi, George Psomas, Panayiotis Dalezis, Paraskevas Aslanidis, Theodora Choli-Papadopoulou, Dimitrios T Trafalis, Panagiotis A Angaridis
Silver(I) complexes bearing heterocyclic thioamide ligands with NH 2 and CF 3 substituents: effect of ligand group substitution on antibacterial and anticancer properties. Dalton transactions (Cambridge, England : 2003) 51 (24) (2022)
Maria V Deligiorgi, Dimitrios T Trafalis
Refining personalized diagnosis, treatment and exploitation of hypothyroidism related to solid nonthyroid cancer. Personalized medicine (2022)
Sofia Sagredou, Panayiotis Dalezis, Eirini Papadopoulou, Maria Voura, Maria V Deligiorgi, Michail Nikolaou, Mihalis I Panayiotidis, George Nasioulas, Vasiliki Sarli, Dimitrios T Trafalis
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. Pharmaceutics 13 (6) (2021)
Sotiris Kyriakou, Venetia Tragkola, Michael Plioukas, Ioannis Anestopoulos, Paschalina S Chatzopoulou, Eirini Sarrou, Dimitrios T Trafalis, Maria V Deligiorgi, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical and Biological Characterization of the Anticancer Potency of Salvia fruticosa in a Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 10 (11) (2021)
Nikolaos Nikoleousakos, Panayiotis Dalezis, Aikaterini Polonifi, Elena G Geromichalou, Sofia Sagredou, Constantinos E Alifieris, Maria V Deligiorgi, Vasiliki Sarli, Dimitrios T Trafalis
Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes in a Cell-Free Assay. Biomedicines 9 (8) (2021)
Dimitrios T Trafalis, Sofia Sagredou, Panayiotis Dalezis, Maria Voura, Stella Fountoulaki, Nikolaos Nikoleousakos, Konstantinos Almpanakis, Maria V Deligiorgi, Vasiliki Sarli
Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation. Pharmaceutics 13 (4) (2021)
Maria V Deligiorgi, Sofia Sagredou, Lampros Vakkas, Dimitrios T Trafalis
The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries. Cancers 13 (21) (2021)
Maria V Deligiorgi, Charis Liapi, Dimitrios T Trafalis
Hypophysitis related to immune checkpoint inhibitors: An intriguing adverse event with many faces. Expert opinion on biological therapy 21 (8) (2021)
Maria V Deligiorgi, Dimitrios T Trafalis
The Intriguing Thyroid Hormones-Lung Cancer Association as Exemplification of the Thyroid Hormones-Cancer Association: Three Decades of Evolving Research. International journal of molecular sciences 23 (1) (2021)
Melina Mitsiogianni, Sotiris Kyriakou, Ioannis Anestopoulos, Dimitrios T Trafalis, Maria V Deligiorgi, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
An Evaluation of the Anti-Carcinogenic Response of Major Isothiocyanates in Non-Metastatic and Metastatic Melanoma Cells. Antioxidants (Basel, Switzerland) 10 (2) (2021)
Maria V Deligiorgi, Gerasimos Siasos, Lampros Vakkas, Dimitrios T Trafalis
Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution. Cancers 13 (22) (2021)
Theodora Chatzisideri, Panayiotis Dalezis, George Leonidis, Spyridon Bousis, Dimitrios T Trafalis, Francesca Bianchini, Vasiliki Sarli
Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins. Future medicinal chemistry 13 (10) (2021)
Maria V Deligiorgi, Dimitrios T Trafalis
Repurposing denosumab in lung cancer beyond counteracting the skeletal related events: an intriguing perspective. Expert opinion on biological therapy 20 (11) (2020)
Maria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Repurposing denosumab in breast cancer beyond prevention of skeletal related events: Could nonclinical data be translated into clinical practice? Expert review of clinical pharmacology 13 (11) (2020)
Maria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Prophylactic lymph node dissection in clinically N0 differentiated thyroid carcinoma: example of personalized treatment. Personalized medicine 17 (4) (2020)
Maria V Deligiorgi, Charis Liapi, Dimitrios T Trafalis
How Far Are We from Prescribing Fasting as Anticancer Medicine? International journal of molecular sciences 21 (23) (2020)
Maria V Deligiorgi, Dimitrios T Trafalis
The safety profile of denosumab in oncology beyond the safety of denosumab as an anti-osteoporotic agent: still more to learn. Expert opinion on drug safety 20 (2) (2020)
Dimitrios T Trafalis, Aikaterini Polonifi, Panayiotis Dalezis, Nikolaos Nikoleousakos, Sotirios Katsamakas, Vasiliki Sarli
Targeting on poly(ADP-ribose) polymerase activity with DNA-damaging hybrid lactam-steroid alkylators in wild-type and BRCA1-mutated ovarian cancer cells. Chemical biology & drug design 90 (5) (2017)

Dimitrios T Trafalis.css-eqlu8i{font-size:small;padding-left:4px;} (Dimitrios Trafalis)

Publication Activity (10 Years)

Top Topics

Top Venues

Dimitrios T Trafalis (Dimitrios Trafalis)